Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-19-046031

General Counsel/Secretary bought 5,000 shares at $1.02 ($5,100)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Leavitt Chase C. General Counsel/Secretary 2019-08-13 Purchase +5,000 $1.02 $5,100 5,000 D: show line 1 in the form
Open-market purchases · 5,000 sh · avg $1.02 · $5,100

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Leavitt Chase C. General Counsel/Secretary 2019-07-31 Grant or award · Employee Stock Option (Right to Buy) +125,000 125,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…